LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
Regulatory expert Julie Ballard shares her first thoughts on the final rule for lab-developed tests and immediate steps for labs
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
Juan Antonio Retamero, MD, shares his thoughts on recent trends in AI and digital pathology, and how they may progress.
Healthcare leader Steve Serota discusses a new partnership and how it is bringing high-quality lab testing to underserved areas.
Expert discusses the increasing number of attacks against the healthcare industry and how labs can protect their systems and data.
G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight
The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.
Billing and coding consultant Diana Voorhees shares her tips to ensure compliance when billing laboratory services.
The FDA recently submitted its own proposed rule relating to lab-developed test regulation for review.